Other
Parent Project Muscular Dystrophy
Total Trials
6
Recruiting
2
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
Phase 1
2(66.7%)
Early Phase 1
1(33.3%)
3Total
Phase 1(2)
Early Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT06692426Phase 1Recruiting
Trial of Cell Based Therapy for DMD
Role: collaborator
NCT02069756Recruiting
The Duchenne Registry
Role: collaborator
NCT02972580Active Not Recruiting
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
Role: collaborator
NCT01519349Phase 1Completed
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Role: collaborator
NCT01359670Early Phase 1Completed
Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
Role: collaborator
NCT00468832Unknown
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
Role: collaborator
All 6 trials loaded